home / stock / mirm / mirm message board
Subject | By | Source | When |
---|---|---|---|
I agree ! | Ganz | investorshub | 01/30/2023 4:46:13 PM |
I'm not sure there's a more intriguing small | historyperson | investorshub | 01/30/2023 1:45:09 AM |
Float, smote, keep an eye on this one. | Ganz | investorshub | 01/25/2023 4:55:43 PM |
The float is so small | Cosa | investorshub | 01/23/2023 7:05:41 PM |
Riztheinvestor: CYDY buyout 50 bucks 2023 | Riztheinvestor | investorshangout | 04/06/2022 7:39:11 PM |
Not many peeps here, this is a breakout | Ganz | investorshub | 02/09/2022 4:15:03 PM |
* * $MIRM Video Chart 12-18-2019 * * | ClayTrader | investorshub | 12/18/2019 10:09:21 PM |
Nice | CyrusDaVirus | investorshub | 12/18/2019 5:53:24 PM |
Just took a position today. Looking good | zc182 | investorshub | 12/18/2019 1:42:08 AM |
News, Short Squeeze, Breakout and More Instantly...
Mirum Pharmaceuticals Inc. Company Name:
MIRM Stock Symbol:
NYSE Market:
- First quarter 2024 total revenue of $69.2 million, on track to achieve full-year guidance of $310 to $320 million - FDA approval of LIVMARLI for cholestatic pruritus in PFIC patients achieved in March - Volixibat VISTAS and VANTAGE interim analyses scheduled for June of 2024 - Cash balanc...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will present at the Citizens JMP Life Sciences Conference in ...